Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
about
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@en
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@nl
type
label
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@en
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@nl
prefLabel
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@en
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Excision repair cross-compleme ...... with neoadjuvant chemotherapy.
@en
P2093
Federica Sella
Francesca Michelacci
Giovanna Magagnoli
Stefania Benini
Stefano Ferrari
P2860
P304
P356
10.1111/HIS.12653
P577
2015-03-05T00:00:00Z